世界の後期慢性腎臓病治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Late Stage Chronic Kidney Disease Drugs Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4413 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、後期慢性腎臓病治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カルシウム受容体刺激薬、ビタミンDステロール、カリウムバインダー、その他）、用途別市場規模（病院薬局、オンライン薬局、小売薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・後期慢性腎臓病治療薬の市場動向 ・企業の競争状況、市場シェア ・後期慢性腎臓病治療薬の種類別市場規模と予測2016-2027（カルシウム受容体刺激薬、ビタミンDステロール、カリウムバインダー、その他） ・後期慢性腎臓病治療薬の用途別市場規模と予測2016-2027（病院薬局、オンライン薬局、小売薬局） ・後期慢性腎臓病治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・後期慢性腎臓病治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・後期慢性腎臓病治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・後期慢性腎臓病治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・後期慢性腎臓病治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AbbVie、Amgen、Ardelyx、AstraZeneca、Deltanoid、Akebia Therapeutics、Kyowa Hakko Kirin、OPKO Health、Vifor Pharma、Sanofi、Shield Therapeutics、Shire、Spectrum、ZS Pharma） ・結論

Late stage chronic kidney disease therapeutics can be defined as the drugs which are used for the treatment of late-stage CKD – Induced, Hyperphosphatemia, Hyperparathyroidism and Hyperkalemia.

Market Analysis and Insights: Global Late Stage Chronic Kidney Disease Drugs Market
The global Late Stage Chronic Kidney Disease Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Late Stage Chronic Kidney Disease Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Late Stage Chronic Kidney Disease Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Late Stage Chronic Kidney Disease Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Late Stage Chronic Kidney Disease Drugs market.

Global Late Stage Chronic Kidney Disease Drugs Scope and Market Size
Late Stage Chronic Kidney Disease Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Late Stage Chronic Kidney Disease Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Calcimimetics
Vitamin D Sterols
Potassium Binders
Others

Segment by Application
Hospital Pharmacies
Online Pharnacies
Retail Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AbbVie
Amgen
Ardelyx
AstraZeneca
Deltanoid
Akebia Therapeutics
Kyowa Hakko Kirin
OPKO Health
Vifor Pharma
Sanofi
Shield Therapeutics
Shire
Spectrum
ZS Pharma

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Late Stage Chronic Kidney Disease Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Calcimimetics
1.2.3 Vitamin D Sterols
1.2.4 Potassium Binders
1.2.5 Others
1.3 Market by Application
1.3.1 Global Late Stage Chronic Kidney Disease Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Online Pharnacies
1.3.4 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Late Stage Chronic Kidney Disease Drugs Market Perspective (2016-2027)
2.2 Late Stage Chronic Kidney Disease Drugs Growth Trends by Regions
2.2.1 Late Stage Chronic Kidney Disease Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Late Stage Chronic Kidney Disease Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Late Stage Chronic Kidney Disease Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Late Stage Chronic Kidney Disease Drugs Industry Dynamic
2.3.1 Late Stage Chronic Kidney Disease Drugs Market Trends
2.3.2 Late Stage Chronic Kidney Disease Drugs Market Drivers
2.3.3 Late Stage Chronic Kidney Disease Drugs Market Challenges
2.3.4 Late Stage Chronic Kidney Disease Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Late Stage Chronic Kidney Disease Drugs Players by Revenue
3.1.1 Global Top Late Stage Chronic Kidney Disease Drugs Players by Revenue (2016-2021)
3.1.2 Global Late Stage Chronic Kidney Disease Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Late Stage Chronic Kidney Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Late Stage Chronic Kidney Disease Drugs Revenue
3.4 Global Late Stage Chronic Kidney Disease Drugs Market Concentration Ratio
3.4.1 Global Late Stage Chronic Kidney Disease Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Late Stage Chronic Kidney Disease Drugs Revenue in 2020
3.5 Late Stage Chronic Kidney Disease Drugs Key Players Head office and Area Served
3.6 Key Players Late Stage Chronic Kidney Disease Drugs Product Solution and Service
3.7 Date of Enter into Late Stage Chronic Kidney Disease Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Late Stage Chronic Kidney Disease Drugs Breakdown Data by Type
4.1 Global Late Stage Chronic Kidney Disease Drugs Historic Market Size by Type (2016-2021)
4.2 Global Late Stage Chronic Kidney Disease Drugs Forecasted Market Size by Type (2022-2027)

5 Late Stage Chronic Kidney Disease Drugs Breakdown Data by Application
5.1 Global Late Stage Chronic Kidney Disease Drugs Historic Market Size by Application (2016-2021)
5.2 Global Late Stage Chronic Kidney Disease Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Late Stage Chronic Kidney Disease Drugs Market Size (2016-2027)
6.2 North America Late Stage Chronic Kidney Disease Drugs Market Size by Type
6.2.1 North America Late Stage Chronic Kidney Disease Drugs Market Size by Type (2016-2021)
6.2.2 North America Late Stage Chronic Kidney Disease Drugs Market Size by Type (2022-2027)
6.2.3 North America Late Stage Chronic Kidney Disease Drugs Market Size by Type (2016-2027)
6.3 North America Late Stage Chronic Kidney Disease Drugs Market Size by Application
6.3.1 North America Late Stage Chronic Kidney Disease Drugs Market Size by Application (2016-2021)
6.3.2 North America Late Stage Chronic Kidney Disease Drugs Market Size by Application (2022-2027)
6.3.3 North America Late Stage Chronic Kidney Disease Drugs Market Size by Application (2016-2027)
6.4 North America Late Stage Chronic Kidney Disease Drugs Market Size by Country
6.4.1 North America Late Stage Chronic Kidney Disease Drugs Market Size by Country (2016-2021)
6.4.2 North America Late Stage Chronic Kidney Disease Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Late Stage Chronic Kidney Disease Drugs Market Size (2016-2027)
7.2 Europe Late Stage Chronic Kidney Disease Drugs Market Size by Type
7.2.1 Europe Late Stage Chronic Kidney Disease Drugs Market Size by Type (2016-2021)
7.2.2 Europe Late Stage Chronic Kidney Disease Drugs Market Size by Type (2022-2027)
7.2.3 Europe Late Stage Chronic Kidney Disease Drugs Market Size by Type (2016-2027)
7.3 Europe Late Stage Chronic Kidney Disease Drugs Market Size by Application
7.3.1 Europe Late Stage Chronic Kidney Disease Drugs Market Size by Application (2016-2021)
7.3.2 Europe Late Stage Chronic Kidney Disease Drugs Market Size by Application (2022-2027)
7.3.3 Europe Late Stage Chronic Kidney Disease Drugs Market Size by Application (2016-2027)
7.4 Europe Late Stage Chronic Kidney Disease Drugs Market Size by Country
7.4.1 Europe Late Stage Chronic Kidney Disease Drugs Market Size by Country (2016-2021)
7.4.2 Europe Late Stage Chronic Kidney Disease Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market Size (2016-2027)
8.2 Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market Size by Type
8.2.1 Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market Size by Application
8.3.1 Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market Size by Region
8.4.1 Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Late Stage Chronic Kidney Disease Drugs Market Size (2016-2027)
9.2 Latin America Late Stage Chronic Kidney Disease Drugs Market Size by Type
9.2.1 Latin America Late Stage Chronic Kidney Disease Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Late Stage Chronic Kidney Disease Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Late Stage Chronic Kidney Disease Drugs Market Size by Type (2016-2027)
9.3 Latin America Late Stage Chronic Kidney Disease Drugs Market Size by Application
9.3.1 Latin America Late Stage Chronic Kidney Disease Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Late Stage Chronic Kidney Disease Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Late Stage Chronic Kidney Disease Drugs Market Size by Application (2016-2027)
9.4 Latin America Late Stage Chronic Kidney Disease Drugs Market Size by Country
9.4.1 Latin America Late Stage Chronic Kidney Disease Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Late Stage Chronic Kidney Disease Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Late Stage Chronic Kidney Disease Drugs Market Size (2016-2027)
10.2 Middle East & Africa Late Stage Chronic Kidney Disease Drugs Market Size by Type
10.2.1 Middle East & Africa Late Stage Chronic Kidney Disease Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Late Stage Chronic Kidney Disease Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Late Stage Chronic Kidney Disease Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Late Stage Chronic Kidney Disease Drugs Market Size by Application
10.3.1 Middle East & Africa Late Stage Chronic Kidney Disease Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Late Stage Chronic Kidney Disease Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Late Stage Chronic Kidney Disease Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Late Stage Chronic Kidney Disease Drugs Market Size by Country
10.4.1 Middle East & Africa Late Stage Chronic Kidney Disease Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Late Stage Chronic Kidney Disease Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Late Stage Chronic Kidney Disease Drugs Introduction
11.1.4 AbbVie Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
11.1.5 AbbVie Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Late Stage Chronic Kidney Disease Drugs Introduction
11.2.4 Amgen Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
11.2.5 Amgen Recent Development
11.3 Ardelyx
11.3.1 Ardelyx Company Details
11.3.2 Ardelyx Business Overview
11.3.3 Ardelyx Late Stage Chronic Kidney Disease Drugs Introduction
11.3.4 Ardelyx Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
11.3.5 Ardelyx Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Details
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Late Stage Chronic Kidney Disease Drugs Introduction
11.4.4 AstraZeneca Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
11.4.5 AstraZeneca Recent Development
11.5 Deltanoid
11.5.1 Deltanoid Company Details
11.5.2 Deltanoid Business Overview
11.5.3 Deltanoid Late Stage Chronic Kidney Disease Drugs Introduction
11.5.4 Deltanoid Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
11.5.5 Deltanoid Recent Development
11.6 Akebia Therapeutics
11.6.1 Akebia Therapeutics Company Details
11.6.2 Akebia Therapeutics Business Overview
11.6.3 Akebia Therapeutics Late Stage Chronic Kidney Disease Drugs Introduction
11.6.4 Akebia Therapeutics Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
11.6.5 Akebia Therapeutics Recent Development
11.7 Kyowa Hakko Kirin
11.7.1 Kyowa Hakko Kirin Company Details
11.7.2 Kyowa Hakko Kirin Business Overview
11.7.3 Kyowa Hakko Kirin Late Stage Chronic Kidney Disease Drugs Introduction
11.7.4 Kyowa Hakko Kirin Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
11.7.5 Kyowa Hakko Kirin Recent Development
11.8 OPKO Health
11.8.1 OPKO Health Company Details
11.8.2 OPKO Health Business Overview
11.8.3 OPKO Health Late Stage Chronic Kidney Disease Drugs Introduction
11.8.4 OPKO Health Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
11.8.5 OPKO Health Recent Development
11.9 Vifor Pharma
11.9.1 Vifor Pharma Company Details
11.9.2 Vifor Pharma Business Overview
11.9.3 Vifor Pharma Late Stage Chronic Kidney Disease Drugs Introduction
11.9.4 Vifor Pharma Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
11.9.5 Vifor Pharma Recent Development
11.10 Sanofi
11.10.1 Sanofi Company Details
11.10.2 Sanofi Business Overview
11.10.3 Sanofi Late Stage Chronic Kidney Disease Drugs Introduction
11.10.4 Sanofi Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
11.10.5 Sanofi Recent Development
11.11 Shield Therapeutics
11.11.1 Shield Therapeutics Company Details
11.11.2 Shield Therapeutics Business Overview
11.11.3 Shield Therapeutics Late Stage Chronic Kidney Disease Drugs Introduction
11.11.4 Shield Therapeutics Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
11.11.5 Shield Therapeutics Recent Development
11.12 Shire
11.12.1 Shire Company Details
11.12.2 Shire Business Overview
11.12.3 Shire Late Stage Chronic Kidney Disease Drugs Introduction
11.12.4 Shire Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
11.12.5 Shire Recent Development
11.13 Spectrum
11.13.1 Spectrum Company Details
11.13.2 Spectrum Business Overview
11.13.3 Spectrum Late Stage Chronic Kidney Disease Drugs Introduction
11.13.4 Spectrum Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
11.13.5 Spectrum Recent Development
11.14 ZS Pharma
11.14.1 ZS Pharma Company Details
11.14.2 ZS Pharma Business Overview
11.14.3 ZS Pharma Late Stage Chronic Kidney Disease Drugs Introduction
11.14.4 ZS Pharma Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
11.14.5 ZS Pharma Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Late Stage Chronic Kidney Disease Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Calcimimetics
Table 3. Key Players of Vitamin D Sterols
Table 4. Key Players of Potassium Binders
Table 5. Key Players of Others
Table 6. Global Late Stage Chronic Kidney Disease Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Late Stage Chronic Kidney Disease Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Late Stage Chronic Kidney Disease Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Late Stage Chronic Kidney Disease Drugs Market Share by Regions (2016-2021)
Table 10. Global Late Stage Chronic Kidney Disease Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Late Stage Chronic Kidney Disease Drugs Market Share by Regions (2022-2027)
Table 12. Late Stage Chronic Kidney Disease Drugs Market Trends
Table 13. Late Stage Chronic Kidney Disease Drugs Market Drivers
Table 14. Late Stage Chronic Kidney Disease Drugs Market Challenges
Table 15. Late Stage Chronic Kidney Disease Drugs Market Restraints
Table 16. Global Late Stage Chronic Kidney Disease Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Late Stage Chronic Kidney Disease Drugs Market Share by Players (2016-2021)
Table 18. Global Top Late Stage Chronic Kidney Disease Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Late Stage Chronic Kidney Disease Drugs as of 2020)
Table 19. Ranking of Global Top Late Stage Chronic Kidney Disease Drugs Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Late Stage Chronic Kidney Disease Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Late Stage Chronic Kidney Disease Drugs Product Solution and Service
Table 23. Date of Enter into Late Stage Chronic Kidney Disease Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Late Stage Chronic Kidney Disease Drugs Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Late Stage Chronic Kidney Disease Drugs Revenue Market Share by Type (2016-2021)
Table 27. Global Late Stage Chronic Kidney Disease Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Late Stage Chronic Kidney Disease Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Late Stage Chronic Kidney Disease Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Late Stage Chronic Kidney Disease Drugs Revenue Market Share by Application (2016-2021)
Table 31. Global Late Stage Chronic Kidney Disease Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Late Stage Chronic Kidney Disease Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Late Stage Chronic Kidney Disease Drugs Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Late Stage Chronic Kidney Disease Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Late Stage Chronic Kidney Disease Drugs Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Late Stage Chronic Kidney Disease Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Late Stage Chronic Kidney Disease Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Late Stage Chronic Kidney Disease Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Late Stage Chronic Kidney Disease Drugs Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Late Stage Chronic Kidney Disease Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Late Stage Chronic Kidney Disease Drugs Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Late Stage Chronic Kidney Disease Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Late Stage Chronic Kidney Disease Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Late Stage Chronic Kidney Disease Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Late Stage Chronic Kidney Disease Drugs Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Late Stage Chronic Kidney Disease Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Late Stage Chronic Kidney Disease Drugs Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Late Stage Chronic Kidney Disease Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Late Stage Chronic Kidney Disease Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Late Stage Chronic Kidney Disease Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Late Stage Chronic Kidney Disease Drugs Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Late Stage Chronic Kidney Disease Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Late Stage Chronic Kidney Disease Drugs Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Late Stage Chronic Kidney Disease Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Late Stage Chronic Kidney Disease Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Late Stage Chronic Kidney Disease Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 63. AbbVie Company Details
Table 64. AbbVie Business Overview
Table 65. AbbVie Late Stage Chronic Kidney Disease Drugs Product
Table 66. AbbVie Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021) & (US$ Million)
Table 67. AbbVie Recent Development
Table 68. Amgen Company Details
Table 69. Amgen Business Overview
Table 70. Amgen Late Stage Chronic Kidney Disease Drugs Product
Table 71. Amgen Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021) & (US$ Million)
Table 72. Amgen Recent Development
Table 73. Ardelyx Company Details
Table 74. Ardelyx Business Overview
Table 75. Ardelyx Late Stage Chronic Kidney Disease Drugs Product
Table 76. Ardelyx Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021) & (US$ Million)
Table 77. Ardelyx Recent Development
Table 78. AstraZeneca Company Details
Table 79. AstraZeneca Business Overview
Table 80. AstraZeneca Late Stage Chronic Kidney Disease Drugs Product
Table 81. AstraZeneca Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021) & (US$ Million)
Table 82. AstraZeneca Recent Development
Table 83. Deltanoid Company Details
Table 84. Deltanoid Business Overview
Table 85. Deltanoid Late Stage Chronic Kidney Disease Drugs Product
Table 86. Deltanoid Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021) & (US$ Million)
Table 87. Deltanoid Recent Development
Table 88. Akebia Therapeutics Company Details
Table 89. Akebia Therapeutics Business Overview
Table 90. Akebia Therapeutics Late Stage Chronic Kidney Disease Drugs Product
Table 91. Akebia Therapeutics Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021) & (US$ Million)
Table 92. Akebia Therapeutics Recent Development
Table 93. Kyowa Hakko Kirin Company Details
Table 94. Kyowa Hakko Kirin Business Overview
Table 95. Kyowa Hakko Kirin Late Stage Chronic Kidney Disease Drugs Product
Table 96. Kyowa Hakko Kirin Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021) & (US$ Million)
Table 97. Kyowa Hakko Kirin Recent Development
Table 98. OPKO Health Company Details
Table 99. OPKO Health Business Overview
Table 100. OPKO Health Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021) & (US$ Million)
Table 101. OPKO Health Recent Development
Table 102. Vifor Pharma Company Details
Table 103. Vifor Pharma Business Overview
Table 104. Vifor Pharma Late Stage Chronic Kidney Disease Drugs Product
Table 105. Vifor Pharma Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021) & (US$ Million)
Table 106. Vifor Pharma Recent Development
Table 107. Sanofi Company Details
Table 108. Sanofi Business Overview
Table 109. Sanofi Late Stage Chronic Kidney Disease Drugs Product
Table 110. Sanofi Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021) & (US$ Million)
Table 111. Sanofi Recent Development
Table 112. Shield Therapeutics Company Details
Table 113. Shield Therapeutics Business Overview
Table 114. Shield Therapeutics Late Stage Chronic Kidney Disease Drugs Product
Table 115. Shield Therapeutics Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021) & (US$ Million)
Table 116. Shield Therapeutics Recent Development
Table 117. Shire Company Details
Table 118. Shire Business Overview
Table 119. Shire Late Stage Chronic Kidney Disease Drugs Product
Table 120. Shire Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021) & (US$ Million)
Table 121. Shire Recent Development
Table 122. Spectrum Company Details
Table 123. Spectrum Business Overview
Table 124. Spectrum Late Stage Chronic Kidney Disease Drugs Product
Table 125. Spectrum Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021) & (US$ Million)
Table 126. Spectrum Recent Development
Table 127. ZS Pharma Company Details
Table 128. ZS Pharma Business Overview
Table 129. ZS Pharma Late Stage Chronic Kidney Disease Drugs Product
Table 130. ZS Pharma Revenue in Late Stage Chronic Kidney Disease Drugs Business (2016-2021) & (US$ Million)
Table 131. ZS Pharma Recent Development
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Late Stage Chronic Kidney Disease Drugs Market Share by Type: 2020 VS 2027
Figure 2. Calcimimetics Features
Figure 3. Vitamin D Sterols Features
Figure 4. Potassium Binders Features
Figure 5. Others Features
Figure 6. Global Late Stage Chronic Kidney Disease Drugs Market Share by Application: 2020 VS 2027
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Online Pharnacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Late Stage Chronic Kidney Disease Drugs Report Years Considered
Figure 11. Global Late Stage Chronic Kidney Disease Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Late Stage Chronic Kidney Disease Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Late Stage Chronic Kidney Disease Drugs Market Share by Regions: 2020 VS 2027
Figure 14. Global Late Stage Chronic Kidney Disease Drugs Market Share by Regions (2022-2027)
Figure 15. Global Late Stage Chronic Kidney Disease Drugs Market Share by Players in 2020
Figure 16. Global Top Late Stage Chronic Kidney Disease Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Late Stage Chronic Kidney Disease Drugs as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Late Stage Chronic Kidney Disease Drugs Revenue in 2020
Figure 18. Global Late Stage Chronic Kidney Disease Drugs Revenue Market Share by Type (2016-2021)
Figure 19. Global Late Stage Chronic Kidney Disease Drugs Revenue Market Share by Type (2022-2027)
Figure 20. North America Late Stage Chronic Kidney Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Late Stage Chronic Kidney Disease Drugs Market Share by Type (2016-2027)
Figure 22. North America Late Stage Chronic Kidney Disease Drugs Market Share by Application (2016-2027)
Figure 23. North America Late Stage Chronic Kidney Disease Drugs Market Share by Country (2016-2027)
Figure 24. United States Late Stage Chronic Kidney Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Late Stage Chronic Kidney Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Late Stage Chronic Kidney Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Late Stage Chronic Kidney Disease Drugs Market Share by Type (2016-2027)
Figure 28. Europe Late Stage Chronic Kidney Disease Drugs Market Share by Application (2016-2027)
Figure 29. Europe Late Stage Chronic Kidney Disease Drugs Market Share by Country (2016-2027)
Figure 30. Germany Late Stage Chronic Kidney Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Late Stage Chronic Kidney Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Late Stage Chronic Kidney Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Late Stage Chronic Kidney Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Late Stage Chronic Kidney Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Late Stage Chronic Kidney Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Late Stage Chronic Kidney Disease Drugs Market Share by Region (2016-2027)
Figure 40. China Late Stage Chronic Kidney Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Late Stage Chronic Kidney Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Late Stage Chronic Kidney Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Late Stage Chronic Kidney Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Late Stage Chronic Kidney Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Late Stage Chronic Kidney Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Late Stage Chronic Kidney Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Late Stage Chronic Kidney Disease Drugs Market Share by Type (2016-2027)
Figure 48. Latin America Late Stage Chronic Kidney Disease Drugs Market Share by Application (2016-2027)
Figure 49. Latin America Late Stage Chronic Kidney Disease Drugs Market Share by Country (2016-2027)
Figure 50. Mexico Late Stage Chronic Kidney Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Late Stage Chronic Kidney Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Late Stage Chronic Kidney Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Late Stage Chronic Kidney Disease Drugs Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Late Stage Chronic Kidney Disease Drugs Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Late Stage Chronic Kidney Disease Drugs Market Share by Country (2016-2027)
Figure 56. Turkey Late Stage Chronic Kidney Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Late Stage Chronic Kidney Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Late Stage Chronic Kidney Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. AbbVie Revenue Growth Rate in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
Figure 60. Amgen Revenue Growth Rate in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
Figure 61. Ardelyx Revenue Growth Rate in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
Figure 62. AstraZeneca Revenue Growth Rate in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
Figure 63. Deltanoid Revenue Growth Rate in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
Figure 64. Akebia Therapeutics Revenue Growth Rate in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
Figure 65. Kyowa Hakko Kirin Revenue Growth Rate in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
Figure 66. OPKO Health Revenue Growth Rate in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
Figure 67. Vifor Pharma Revenue Growth Rate in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
Figure 68. Sanofi Revenue Growth Rate in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
Figure 69. Shield Therapeutics Revenue Growth Rate in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
Figure 70. Shire Revenue Growth Rate in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
Figure 71. Spectrum Revenue Growth Rate in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
Figure 72. ZS Pharma Revenue Growth Rate in Late Stage Chronic Kidney Disease Drugs Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

---